Newborn Screening Testing Market Analysis 2026

Global Newborn Screening Testing Market Analysis from 2022 to 2034 Containing Market Size, Share along with its CAGR, Forecast and Trends

Newborn Screening Testing Market Report Description

We have various report editions of Newborn Screening Testing Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Newborn Screening Testing Market Insights Video

Competitive Landscape of the Newborn Screening Testing Market

The competitive landscape of the newborn screening testing market is characterized by a mix of established players and emerging innovators. Leading companies like PerkinElmer, Abbott, and Roche dominate with advanced technologies and comprehensive screening solutions. They focus on enhancing test accuracy and expanding screening panels. New entrants and specialized firms, such as Glycominds, drive innovation in niche areas. Competition is driven by technological advancements, regulatory compliance, and the growing demand for early diagnostic tools and comprehensive screening programs.

In June 2021, Texas Health and Human Services introduced newborn screening for Spinal Muscular Atrophy (SMA), contributing to the growing importance of early diagnosis in preventing severe health outcomes. As more such initiatives are implemented, the newborn screening market is poised for substantial growth during the forecast period. (Source: https://www.dshs.texas.gov/newborn-screening-program) In March 2022, Oxford University has launched a population-based newborn screening study in the Thames Valley region. This screening will be conducted through the standard UK newborn blood spot screening process, utilizing the extra sample from a newborn's Guthrie card (dried blood spot). (Source: https://www.ox.ac.uk/news/2022-03-11-first-uk-pilot-study-newborn-screening-spinal-muscular-atrophy-launched-oxford) In July 2020, PerkinElmer Inc. introduced a dry blood spot (DBS) test for SARS-CoV-2 IgG using its GSP/DELFIA platform, capable of processing up to 5,000 samples daily. The test runs on PerkinElmer's GSP analyzer, and with the DELFIA platform’s time-resolved fluorescence (TRF), it helps screen over 30% of all newborns globally, covering 32 countries. (Source: https://www.clinicallab.com/perkinelmer-releases-new-dried-blood-spot-based-covid-19-serology-test-23359)

Top Companies Market Share in Newborn Screening Testing Industry: (In no particular order of Rank)

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive)

Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Newborn Screening Testing Market

Which Region Dominates the Newborn Screening Testing Market in 2024?

According to Cognitive Market Research, North America currently dominates the Newborn Screening Testing market, and the region is expected to have significant growth during the projected period. This is due to the region's well-established healthcare infrastructure and extensive government programs mandating newborn screenings. High awareness levels among parents and healthcare providers, along with significant investments in advanced diagnostic technologies, contribute to market dominance. Additionally, robust research and development activities, coupled with a high standard of healthcare services, support early detection and comprehensive screening, driving growth in the region.

Which Region is Expanding at the Fastest CAGR?

The Asia Pacific region is growing at the fastest CAGR in the newborn screening testing market due to increasing healthcare investments, expanding healthcare infrastructure, and rising awareness about early detection of congenital disorders. Government initiatives to improve healthcare access and the growing prevalence of genetic disorders drive demand. Additionally, rising disposable incomes and urbanization contribute to higher healthcare spending, fostering adoption of advanced newborn screening technologies and services in the region.

The current report Scope analyzes Newborn Screening Testing Market on 6 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (East Africa, West Africa, North Africa, South Africa)

The above graph is for illustrative purposes only.

North America Newborn Screening Testing Market Analysis

According to Cognitive Market Research, the global Newborn Screening Testing market size was estimated at USD 812.5 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 325.0 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.2% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Newborn Screening Testing market with a market size of USD 256.43 million in 2024 and is projected to grow at a CAGR of 6.0% during the forecast period. The U.S. market's increasing government initiatives for early detection of genetic disorders, a well-established healthcare infrastructure, and rising awareness among parents about the benefits of newborn screening is driving the Newborn Screening Testing market.
• The Canada Newborn Screening Testing market had a market share of USD 39.00 million in 2024 and is projected to grow at a CAGR of 7.0% during the forecast period. Canada’s higher healthcare spending is driving the Newborn Screening Testing market.
• The Mexico Newborn Screening Testing market is projected to witness growth at a CAGR of 6.7% during the forecast period, with a market size of USD 29.58 million in 2024.

Europe Newborn Screening Testing Market Analysis

According to Cognitive Market Research, the global Newborn Screening Testing market size was estimated at USD 812.5 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 395.55 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.5% from 2024 to 2031.

• The United Kingdom Newborn Screening Testing market had a market share of USD 40.95 million in 2024 and is projected to grow at a CAGR of 7.3% during the forecast period. In the UK, Newborn Screening Testing sales witness an upswing due to strong government mandates for screening programs and rising awareness about early detection of genetic and metabolic disorders.
• The France Newborn Screening Testing market is projected to witness growth at a CAGR of 5.7% during the forecast period, with a market size of USD 22.43 million in 2024.
• According to Cognitive Market Research, the German Newborn Screening Testing market size was valued at USD 48.26 million in 2024 and is projected to grow at a CAGR of 6.7% during the forecast period. In Germany, Newborn Screening Testing surged due to presence of major market players.
• The Italy Newborn Screening Testing market is projected to witness growth at a CAGR of 5.9% during the forecast period, with a market size of USD 20.96 million in 2024.
• The Russia Newborn Screening Testing market is projected to witness growth at a CAGR of 5.5% during the forecast period, with a market size of USD 37.78 million in 2024.
• The Spain Newborn Screening Testing market is projected to witness growth at a CAGR of 5.6% during the forecast period with a market size of USD 19.99 million in 2024
• The Luxembourg Newborn Screening Testing market is projected to witness growth at a CAGR of 6.6% during the forecast period, with a market size of USD 7.56 million in 2024.
• The Portugal Newborn Screening Testing market is projected to witness growth at a CAGR of 6.3% during the forecast period, with a market size of USD 5.12 million in 2024.
• The Greece Newborn Screening Testing market is projected to witness growth at a CAGR of 6.8% during the forecast period, with a market size of USD 2.93 million in 2024.
• The Rest of Europe's Newborn Screening Testing market is projected to witness growth at a CAGR of 5.2% during the forecast period, with a market size of USD 37.78 million in 2024.

Asia Pacific Newborn Screening Testing Market Analysis

According to Cognitive Market Research, the global Newborn Screening Testing market size was estimated at USD 812.5 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 186.88 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.0% from 2024 to 2031.

• According to Cognitive Market Research, the China Newborn Screening Testing market size was valued at USD 84.09 million in 2024 and is projected to grow at a CAGR of 9.5% during the forecast period. Newborn Screening Testing surged in China due to increasing government initiatives to expand healthcare access and improve infant health outcomes.
• The Japan Newborn Screening Testing market is projected to witness growth at a CAGR of 8.5% during the forecast period, with a market size of USD 25.79 million in 2024.
• The India Newborn Screening Testing market had a market share of USD 22.43 million in 2024 and is projected to grow at a CAGR of 11.8% during the forecast period. India's improving healthcare infrastructure is driving the Newborn Screening Testing market .
• The South Korean Newborn Screening Testing market is projected to witness growth at a CAGR of 9.1% during the forecast period, with a market size of USD 18.69 million in 2024.
• The Australian Newborn Screening Testing market is projected to witness growth at a CAGR of 9.7% during the forecast period, with a market size of USD 9.72 million in 2024.
• The South East Asia Newborn Screening Testing market is projected to witness growth at a CAGR of 11.0% during the forecast period, with a market size of USD 12.89 million in 2024.
• The Rest of Asia Pacific Newborn Screening Testing market is projected to witness growth at a CAGR of 9.8% during the forecast period, with a market size of USD 13.27 million in 2024.

South America Newborn Screening Testing Market Analysis

According to Cognitive Market Research, the global Newborn Screening Testing market size was estimated at USD 812.5 Million, out of which the Latin America held the market share of around 5% of the global revenue with a market size of USD 40.63 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.4% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Newborn Screening Testing market size was valued at USD 17.39 million in 2024 and is projected to grow at a CAGR of 8.0% during the forecast period. Newborn Screening Testing flourished in Brazil due to increasing government efforts to improve child healthcare, particularly through expanded newborn screening programs.
• Argentina's Newborn Screening Testing market had a market share of USD 6.83 million in 2024 and is projected to grow at a CAGR of 8.3% during the forecast period. Argentina's growing healthcare expenditure is driving the Newborn Screening Testing market.
• Colombia Newborn Screening Testing market is projected to witness growth at a CAGR of 7.2% during the forecast period, with a market size of USD 3.62 million in 2024.
• Peru Newborn Screening Testing market is projected to witness growth at a CAGR of 7.6% during the forecast period, with a market size of USD 3.33 million in 2024.
• Chile Newborn Screening Testing market is projected to witness growth at a CAGR of 7.7% during the forecast period, with a market size of USD 2.93 million in 2024.
• The Rest of Latin America's Newborn Screening Testing market is projected to witness growth at a CAGR of 6.5% during the forecast period, with a market size of USD 6.54 million in 2024.

Middle East Newborn Screening Testing Market Analysis

According to Cognitive Market Research, the global Newborn Screening Testing market size was estimated at USD 812.5 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 16.25 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.7% from 2024 to 2031..

• The GCC Countries Newborn Screening Testing market is projected to witness growth at a CAGR of 8.5% during the forecast period, with a market size of USD 6.96 million in 2024. Newborn Screening Testing sales flourish due to the presence of major market players.
• The Egypt Newborn Screening Testing market is projected to witness growth at a CAGR of 8.0% during the forecast period, with a market size of USD 1.71 million in 2024.
• The South Africa Newborn Screening Testing market is projected to witness growth at a CAGR of 8.7% during the forecast period, with a market size of USD 2.57 million in 2024. Newborn Screening Testing sales flourished in South Africa due to increased government initiatives and investments in healthcare infrastructure.
• The Turkey Newborn Screening Testing market is projected to witness growth at a CAGR of 7.2% during the forecast period, with a market size of USD 1.40 million in 2024.
• The Nigeria Newborn Screening Testing market is projected to witness growth at a CAGR of 6.8% during the forecast period, with a market size of USD 1.71 million in 2024.
• The Rest of the MEA Newborn Screening Testing market is projected to witness growth at a CAGR of 6.7% during the forecast period, with a market size of USD 1.92 million in 2024.

Author's Conclusion

Author's Detail

Supriya Yadav

Research Analyst at Cognitive Market Research

LinkedIn | Profile | Book Appointment

Supriya Yadav is a skilled market researcher with strong expertise in the Medical Devices and Consumables industry. Known for her analytical precision and deep interest in healthcare innovation, she focuses on decoding key market trends, technological advancements, and evolving customer needs. Supriya excels at transforming complex industry data into meaningful insights that support strategic decision-making for healthcare stakeholders. Her commitment to understanding the future of medical technologies and improving patient-centric solutions makes her a valuable contributor in this rapidly advancing sector.